Creo Medical Group PLC (AIM:CREO)

Market Cap	51.32M +33.5%
Revenue (ttm)	4.60M
Net Income	500.00K
EPS	-0.00
Shares Out	402.47M
PE Ratio	57.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	129,668
Average Volume	732,150
Open	12.50
Previous Close	12.75
Day's Range	12.25 - 13.00
52-Week Range	9.52 - 18.50
Beta	0.90
RSI	49.57
Earnings Date	May 13, 2026

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needl...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 129
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: CREO

Financial Performance

In 2024, Creo Medical Group's revenue was 4.00 million, a change of 0.00% compared to the previous year's 4.00 million. Losses were -28.70 million, 32.3% more than in 2023.